A
Case of Prostate Adenocarcinoma
with Extracapsular Extension
Treated with Radical
Prostatectomy Followed by
Therapy with Liquid Polyatomic
Oxygen® (LPO)® and
Procarbazine
G.
Barco, M. Mameli, C. Adamo
SUMMARY -
Prostate
tumours
are
the
commonest
cancer
in
many
industrialized
countries
and
the
second
cause
of
death
among
the
male
population
after
lung
cancer.
Prostate
tumours
affect
20-30%
of
men
over
the
age
of
50
years
with
a
rising
incidence
due
to
the
progressive
ageing
of
the
population
-
to
the
extent
that
50%
of
men
over
80
years
have
histological
evidence
of
prostate
cancer.
Having
successfully
managed
other
tumours
administering
liquid
polyatomic
oxygen®,
(LPO)®,
we
treated
prostate
adenocarcinoma
with
procarbazine,
a
cytotoxic
methylhydrazine
derivative,
associated
with
chronic
oxidative
therapy
(COT)
obtained
by
continuous
administration
of
(LPO)® rich
in
superoxide
anion
(O2– ),
using
a
micropump
connected
to
a
Groshong
type
central
venous
catheter
positioned
in
the
patient’s
subclavian
vein.
This
new
approach
led
to
a
complete
resolution
of
the
tumour
which
had
been
unresponsive
to
standard
treatment
following
international
protocols.
The
therapy
had
the
additional
advantage
of
allowing
the
patient
to
enjoy
an
excellent
physical
and
mental
quality
of
life
during
the
treatment.
<< indietro/back